17 Hrs
Source:
Sharjah24
Experimental gene therapy shows promise for inherited blindness
A study conducted by the University of Pittsburgh in the United States, in collaboration with international researchers, investigated an experimental treatment for retinitis pigmentosa, a hereditary disease that destroys light-sensitive retinal cells and gradually leads to vision loss. The treatment involves using "optogenetics" technology by introducing a gene that encodes a light-sensitive protein called "Crimson R" into the remaining retinal cells. This process is activated using special glasses that translate visual data into light patterns to stimulate the protein. The results showed that 7 out of 10 patients experienced improved light sensitivity, with 6 of them achieving significant clinical benefits, leading to better object recognition and localization. This treatment aims to offer an effective option for a disease with no current cure, relying on genetic and optical techniques to significantly enhance patients' quality of life.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)